Cargando…

Organ dysfunction, injury, and failure in cardiogenic shock

BACKGROUND: Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance). MAIN BODY: Although a low cardiac index is a common finding in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirakabe, Akihiro, Matsushita, Masato, Shibata, Yusaku, Shighihara, Shota, Nishigoori, Suguru, Sawatani, Tomofumi, Kiuchi, Kazutaka, Asai, Kuniya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308671/
https://www.ncbi.nlm.nih.gov/pubmed/37386552
http://dx.doi.org/10.1186/s40560-023-00676-1
_version_ 1785066294488334336
author Shirakabe, Akihiro
Matsushita, Masato
Shibata, Yusaku
Shighihara, Shota
Nishigoori, Suguru
Sawatani, Tomofumi
Kiuchi, Kazutaka
Asai, Kuniya
author_facet Shirakabe, Akihiro
Matsushita, Masato
Shibata, Yusaku
Shighihara, Shota
Nishigoori, Suguru
Sawatani, Tomofumi
Kiuchi, Kazutaka
Asai, Kuniya
author_sort Shirakabe, Akihiro
collection PubMed
description BACKGROUND: Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance). MAIN BODY: Although a low cardiac index is a common finding in patients with CS, the ventricular preload, pulmonary capillary wedge pressure, central venous pressure, and systemic vascular resistance might vary between patients. Organ dysfunction has traditionally been attributed to the hypoperfusion of the organ due to either progressive impairment of the cardiac output or intravascular volume depletion secondary to CS. However, research attention has recently shifted from this cardiac output (“forward failure”) to venous congestion (“backward failure”) as the most important hemodynamic determinant. Both hypoperfusion and/or venous congestion by CS could lead to injury, impairment, and failure of target organs (i.e., heart, lungs, kidney, liver, intestines, brain); these effects are associated with an increased mortality rate. Treatment strategies for the prevention, reduction, and reversal of organ injury are warranted to improve morbidity in these patients. The present review summarizes recent data regarding organ dysfunction, injury, and failure. CONCLUSIONS: Early identification and treatment of organ dysfunction, along with hemodynamic stabilization, are key components of the management of patients with CS.
format Online
Article
Text
id pubmed-10308671
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103086712023-06-30 Organ dysfunction, injury, and failure in cardiogenic shock Shirakabe, Akihiro Matsushita, Masato Shibata, Yusaku Shighihara, Shota Nishigoori, Suguru Sawatani, Tomofumi Kiuchi, Kazutaka Asai, Kuniya J Intensive Care Review BACKGROUND: Cardiogenic shock (CS) is caused by primary cardiac dysfunction and induced by various and heterogeneous diseases (e.g., acute impairment of cardiac performance, or acute or chronic impairment of cardiac performance). MAIN BODY: Although a low cardiac index is a common finding in patients with CS, the ventricular preload, pulmonary capillary wedge pressure, central venous pressure, and systemic vascular resistance might vary between patients. Organ dysfunction has traditionally been attributed to the hypoperfusion of the organ due to either progressive impairment of the cardiac output or intravascular volume depletion secondary to CS. However, research attention has recently shifted from this cardiac output (“forward failure”) to venous congestion (“backward failure”) as the most important hemodynamic determinant. Both hypoperfusion and/or venous congestion by CS could lead to injury, impairment, and failure of target organs (i.e., heart, lungs, kidney, liver, intestines, brain); these effects are associated with an increased mortality rate. Treatment strategies for the prevention, reduction, and reversal of organ injury are warranted to improve morbidity in these patients. The present review summarizes recent data regarding organ dysfunction, injury, and failure. CONCLUSIONS: Early identification and treatment of organ dysfunction, along with hemodynamic stabilization, are key components of the management of patients with CS. BioMed Central 2023-06-29 /pmc/articles/PMC10308671/ /pubmed/37386552 http://dx.doi.org/10.1186/s40560-023-00676-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Shirakabe, Akihiro
Matsushita, Masato
Shibata, Yusaku
Shighihara, Shota
Nishigoori, Suguru
Sawatani, Tomofumi
Kiuchi, Kazutaka
Asai, Kuniya
Organ dysfunction, injury, and failure in cardiogenic shock
title Organ dysfunction, injury, and failure in cardiogenic shock
title_full Organ dysfunction, injury, and failure in cardiogenic shock
title_fullStr Organ dysfunction, injury, and failure in cardiogenic shock
title_full_unstemmed Organ dysfunction, injury, and failure in cardiogenic shock
title_short Organ dysfunction, injury, and failure in cardiogenic shock
title_sort organ dysfunction, injury, and failure in cardiogenic shock
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308671/
https://www.ncbi.nlm.nih.gov/pubmed/37386552
http://dx.doi.org/10.1186/s40560-023-00676-1
work_keys_str_mv AT shirakabeakihiro organdysfunctioninjuryandfailureincardiogenicshock
AT matsushitamasato organdysfunctioninjuryandfailureincardiogenicshock
AT shibatayusaku organdysfunctioninjuryandfailureincardiogenicshock
AT shighiharashota organdysfunctioninjuryandfailureincardiogenicshock
AT nishigoorisuguru organdysfunctioninjuryandfailureincardiogenicshock
AT sawatanitomofumi organdysfunctioninjuryandfailureincardiogenicshock
AT kiuchikazutaka organdysfunctioninjuryandfailureincardiogenicshock
AT asaikuniya organdysfunctioninjuryandfailureincardiogenicshock